BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6697402)

  • 21. [Ambulatory treatment of larvate depressions with maprotiline ].
    Vencovský E
    Cesk Psychiatr; 1982 Jun; 78(3):185-9. PubMed ID: 7116496
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of maprotiline on target symptoms of depressive states].
    Faltus F
    Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
    [No Abstract]   [Full Text] [Related]  

  • 23. Nomifensine in the depressed elderly patient: discussion.
    Crook T
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):102-5. PubMed ID: 6370969
    [No Abstract]   [Full Text] [Related]  

  • 24. [Psychopharmacologic treatment of primary depression. Clinical experiments with nomifensine and imipramine].
    Ravizza L; Rebaudengo P; Boccalatte F
    Minerva Psichiatr; 1982; 23(2):87-92. PubMed ID: 7162382
    [No Abstract]   [Full Text] [Related]  

  • 25. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 26. Mianserin versus maprotiline in patients with a depressive syndrome.
    Indaco A; Orefice G; Carrieri P
    Acta Neurol (Napoli); 1984 Apr; 6(2):140-6. PubMed ID: 6741655
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antidepressive action of S-adenosylmethionine compared to nomifensine maleate].
    Scaggion G; Baldan L; Domanin S; Sivo M; Cenci I; Beggio R; Castorina G
    Minerva Psichiatr; 1982; 23(2):93-7. PubMed ID: 6761538
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of maprotiline in primary and secondary anxio-depressive syndromes in the aged].
    Volpi F
    Clin Ter; 1983 Jul; 106(2):95-101. PubMed ID: 6627888
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of depression with maprotiline hydrochloride: multicenter evaluation of efficacy and tolerability.
    Clin Ther; 1983; 5(4):377-84. PubMed ID: 6347381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
    Rektor L; Misaurec J; Horká E; Cerná V
    Act Nerv Super (Praha); 1982 May; 24(2):101-5. PubMed ID: 7102221
    [No Abstract]   [Full Text] [Related]  

  • 31. [Depressive states, occurrence and treatment in family practice. Randomized study of the efficacy of maprotiline (Ludiomil) and flupenthixol (Fluanxol)].
    Sederberg-Olsen P; Lauritsen B; Husfeldt P; Rønne H; Ekstrøm K; Bjørndal F; Holst B; Jakobsen K
    Ugeskr Laeger; 1981 May; 143(22):1383-7. PubMed ID: 7027568
    [No Abstract]   [Full Text] [Related]  

  • 32. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience with treatment of depressions by nomiphenzine (author's transl)].
    Pogády J; Vencovský E; Zizka V
    Cesk Psychiatr; 1981 Feb; 77(1):11-6. PubMed ID: 7018709
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics and efficacy of maprotiline and amitriptyline in endogenous depression: a double-blind controlled trial.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Clin Ther; 1980; 3(4):292-310. PubMed ID: 7023677
    [No Abstract]   [Full Text] [Related]  

  • 35. Supersensitivity and nomifensine in depressed patients.
    Montgomery S; Roy D; Montgomery DB
    Adv Biochem Psychopharmacol; 1982; 32():105-11. PubMed ID: 7046359
    [No Abstract]   [Full Text] [Related]  

  • 36. Recognizing and treating depressed patients with maprotiline.
    Lerfald SC
    Md State Med J; 1982 Nov; 31(11):44-7. PubMed ID: 7176695
    [No Abstract]   [Full Text] [Related]  

  • 37. [Further clinical experiences with maprotiline in endogeneous depressions].
    Náhunek K; Svestka J; Rysánek R; Cesková E
    Act Nerv Super (Praha); 1982 May; 24(2):81-7. PubMed ID: 7048835
    [No Abstract]   [Full Text] [Related]  

  • 38. Position of levoprotiline in the treatment of acute endogenous depression.
    Náhunek K; Svestka J; Cesková E; Rysánek R; Obrovská V; Misurec J; Wendt G
    Act Nerv Super (Praha); 1989 Dec; 31(4):280-1. PubMed ID: 2638110
    [No Abstract]   [Full Text] [Related]  

  • 39. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.